EUVIMEDEUVIMED entdecken
Open Access

Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study

Mouli Nandi, Rana Mondal

Cureus · 21.05.2026

DOI: 10.7759/cureus.109335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 21.05.2026. Verfasst von Mouli Nandi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Luton and Dunstable University Hospital, Luton, GBR. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

gestational hypertensionhomocysteinepostpartum eclampsiasevere hypertensionsevere preeclampsia

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Luton and Dunstable University Hospital, Luton, GBR.

Zitieren

APA

Nandi, M., & Mondal, R. (2026). Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study. Cureus. https://doi.org/10.7759/cureus.109335

Vancouver

Nandi M, Mondal R. Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study. Cureus. 2026. doi:10.7759/cureus.109335

BibTeX
@article{Nandi2026,
  author = {Nandi, Mouli and Mondal, Rana},
  title = {Maternal Serum Homocysteine as a Severity-Linked Biomarker Across the Spectrum of Hypertensive Disorders of Pregnancy: A Prospective Observational Study},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.109335}
}
Kostenlos starten →